Products & Services · Total revenues

ZYNYZ — Total revenues

Incyte ZYNYZ — Total revenues increased by 30.4% to $41.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1275.6%, from $3.01M to $41.39M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026Apr 28, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful market penetration and growing demand for the therapy, while a decrease may signal competitive pressure or market saturation.

Detailed definition

This metric represents the total gross revenue generated specifically from the commercial sales and licensing activities...

Peer comparison

Similar to product-specific revenue reporting in other biopharmaceutical firms, this is comparable to individual drug franchise sales figures reported by peers.

Metric ID: incy_segment_zynyz_total_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$570.00K$98.00K$582.00K$467.00K$651.00K$694.00K$1.37M$3.01M$8.92M$22.67M$31.75M$41.39M
QoQ Change-82.8%+493.9%-19.8%+39.4%+6.6%+97.8%+119.2%+196.5%+154.2%+40.0%+30.4%
YoY Change+14.2%+608.2%+135.9%+544.3%>999%>999%>999%>999%
Range$0.00$41.39M
Avg YoY Growth>999%
Median YoY Growth+939.3%
Current Streak8 quarters growth

Frequently Asked Questions

What is Incyte's zynyz — total revenues?
Incyte (INCY) reported zynyz — total revenues of $41.39M in Q1 2026.
How has Incyte's zynyz — total revenues changed year-over-year?
Incyte's zynyz — total revenues increased by 1275.6% year-over-year, from $3.01M to $41.39M.
What does zynyz — total revenues mean?
The total revenue earned from sales of the ZYNYZ product.